[go: up one dir, main page]

NO20005920L - Mikroemulsjons-forkonsentrater som inneholder en piperidinstoff-P-antagonist - Google Patents

Mikroemulsjons-forkonsentrater som inneholder en piperidinstoff-P-antagonist

Info

Publication number
NO20005920L
NO20005920L NO20005920A NO20005920A NO20005920L NO 20005920 L NO20005920 L NO 20005920L NO 20005920 A NO20005920 A NO 20005920A NO 20005920 A NO20005920 A NO 20005920A NO 20005920 L NO20005920 L NO 20005920L
Authority
NO
Norway
Prior art keywords
piperidine
antagonist
microemulsion preconcentrates
preconcentrates containing
microemulsion
Prior art date
Application number
NO20005920A
Other languages
English (en)
Other versions
NO20005920D0 (no
Inventor
Steffen Lang
Kurt Liechti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811200.6A external-priority patent/GB9811200D0/en
Priority claimed from GBGB9818105.0A external-priority patent/GB9818105D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20005920D0 publication Critical patent/NO20005920D0/no
Publication of NO20005920L publication Critical patent/NO20005920L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005920A 1998-05-26 2000-11-23 Mikroemulsjons-forkonsentrater som inneholder en piperidinstoff-P-antagonist NO20005920L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9811200.6A GB9811200D0 (en) 1998-05-26 1998-05-26 Organic compounds
GBGB9818105.0A GB9818105D0 (en) 1998-08-19 1998-08-19 Organic compounds
PCT/EP1999/003623 WO1999061025A1 (en) 1998-05-26 1999-05-26 Microemulsion preconcentrates containing a piperidine substance p antagonist

Publications (2)

Publication Number Publication Date
NO20005920D0 NO20005920D0 (no) 2000-11-23
NO20005920L true NO20005920L (no) 2001-01-25

Family

ID=26313736

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005920A NO20005920L (no) 1998-05-26 2000-11-23 Mikroemulsjons-forkonsentrater som inneholder en piperidinstoff-P-antagonist

Country Status (31)

Country Link
US (2) US20020156099A1 (no)
EP (1) EP1082119B1 (no)
JP (1) JP4083985B2 (no)
KR (1) KR20010043669A (no)
CN (1) CN1270714C (no)
AR (1) AR018376A1 (no)
AT (1) ATE257380T1 (no)
AU (1) AU755134B2 (no)
BE (1) BE1012143A5 (no)
BR (1) BR9910696A (no)
CA (1) CA2333154C (no)
DE (2) DE19983247T1 (no)
DK (1) DK1082119T3 (no)
ES (1) ES2214859T3 (no)
FR (1) FR2779145B1 (no)
GB (1) GB2353473A (no)
HK (1) HK1035137A1 (no)
HU (1) HUP0102202A3 (no)
ID (1) ID27096A (no)
IL (1) IL139501A0 (no)
IT (1) IT1313551B1 (no)
NO (1) NO20005920L (no)
NZ (1) NZ508325A (no)
PE (1) PE20000537A1 (no)
PL (1) PL344245A1 (no)
PT (1) PT1082119E (no)
RU (1) RU2240121C2 (no)
SK (1) SK17752000A3 (no)
TR (1) TR200003502T2 (no)
TW (1) TW537894B (no)
WO (1) WO1999061025A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW537894B (en) 1998-05-26 2003-06-21 Novartis Ag A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist
US7202282B2 (en) * 2002-04-22 2007-04-10 University Of Florida Microemulsions for selective molecular separation
GB0220953D0 (en) * 2002-09-10 2002-10-23 Novartis Ag Organic compounds
US7842791B2 (en) 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
FR2934953B1 (fr) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions de nanocristaux
FR2934954B1 (fr) 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
FR2934955B1 (fr) 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
FR2935001B1 (fr) * 2008-08-14 2011-12-30 Commissariat Energie Atomique Emulsion fluorescente
CN105209011B (zh) * 2012-12-31 2019-06-25 Jrx生物技术有限公司 液体的局部药用的纳米乳液制剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3305689A1 (de) 1983-02-18 1984-08-23 Mack Chem Pharm Pharmazeutische zubereitung mit retardwirkung
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
MY110227A (en) 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
DE4220616C2 (de) 1992-06-24 1994-12-22 Byk Gulden Lomberg Chem Fab Dexniguldipin zur intravenösen Verabreichung
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
EP0788346B9 (en) * 1994-03-18 2007-02-14 Supernus Pharmaceuticals, Inc. Emulsified drug delivery systems
TW397825B (en) * 1994-10-14 2000-07-11 Novartis Ag Aroyl-piperidine derivatives
GB2308545B (en) 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
FR2728165A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728169A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
KR19980703354A (ko) * 1995-03-27 1998-10-15 나카토미히로타카 피페리딘 유도체
NZ280689A (en) 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
GB9601120D0 (en) 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
AU2898297A (en) 1996-05-24 1998-01-05 Novartis Ag Use of substance p antagonists for treating social phobia
TW537894B (en) 1998-05-26 2003-06-21 Novartis Ag A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist

Also Published As

Publication number Publication date
US6949257B2 (en) 2005-09-27
HK1035137A1 (en) 2001-11-16
KR20010043669A (ko) 2001-05-25
ITMI991164A1 (it) 2000-11-26
TR200003502T2 (tr) 2001-04-20
GB0028506D0 (en) 2001-01-10
JP2002516280A (ja) 2002-06-04
FR2779145B1 (fr) 2004-07-30
CA2333154C (en) 2008-07-08
AR018376A1 (es) 2001-11-14
DE69914077T2 (de) 2004-06-09
JP4083985B2 (ja) 2008-04-30
NO20005920D0 (no) 2000-11-23
FR2779145A1 (fr) 1999-12-03
IT1313551B1 (it) 2002-09-09
HUP0102202A3 (en) 2003-01-28
BR9910696A (pt) 2001-01-30
DE69914077D1 (de) 2004-02-12
RU2240121C2 (ru) 2004-11-20
CN1303285A (zh) 2001-07-11
PE20000537A1 (es) 2000-07-10
DE19983247T1 (de) 2001-05-31
DK1082119T3 (da) 2004-04-13
IL139501A0 (en) 2001-11-25
ES2214859T3 (es) 2004-09-16
EP1082119A1 (en) 2001-03-14
CA2333154A1 (en) 1999-12-02
US20030152626A1 (en) 2003-08-14
NZ508325A (en) 2003-06-30
AU755134B2 (en) 2002-12-05
CN1270714C (zh) 2006-08-23
WO1999061025A1 (en) 1999-12-02
EP1082119B1 (en) 2004-01-07
ATE257380T1 (de) 2004-01-15
BE1012143A5 (fr) 2000-05-02
GB2353473A (en) 2001-02-28
ID27096A (id) 2001-03-01
PL344245A1 (en) 2001-10-08
HUP0102202A2 (hu) 2001-11-28
TW537894B (en) 2003-06-21
SK17752000A3 (sk) 2001-05-10
AU4500899A (en) 1999-12-13
US20020156099A1 (en) 2002-10-24
PT1082119E (pt) 2004-05-31

Similar Documents

Publication Publication Date Title
DK0866117T3 (da) Mikroemulsion
DK1340600T3 (da) Barberapparat
DE69826891D1 (de) Piperidinderivate
NO20005920L (no) Mikroemulsjons-forkonsentrater som inneholder en piperidinstoff-P-antagonist
NO993583D0 (no) Tetningsanordning
DE69916519D1 (de) Münzendiskriminierer
ID20469A (id) Suatu susunan untuk pembuatan kaleng kertas
FI3346U1 (fi) Hiilihapotin
NO995005L (no) En ny fremgangsmåte
FI103524B1 (fi) Liitosjärjestely
FR2769659B1 (fr) Serrure a combinaison preselectionnee
NO995984D0 (no) Tetningsanordning
FR2776164B1 (fr) Godet a rotor
IT243874Y1 (it) Cassetta a muro
DK199900970A (da) Tætningsarrangement
SI1082119T1 (en) Microemulsion preconcentrates containing a piperidine substance p antagonist
FR2769293B3 (fr) Conteneur a encombrement minimum
FI973491A0 (fi) Markeringsmaolning och distributionsfoerpackning som anvaender en laogtrycksbehaollare foer densamma
ATA87997A (de) Bagger
NO993358D0 (no) Flaskekasse
FR2776692B1 (fr) Machine a platrer les plafonds
FR2786165B1 (fr) Coiffes a presentation amelioree
DK199801282A (da) Blokkarton
FI974152A0 (fi) Stuproersfaeste som skyddar vaeggen mot rinnande vatten
ITPE980006A1 (it) Il castracastagne a punteruolo

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application